Hepatocellular carcinoma--an update.
Primary hepatocellular carcinoma (HCC) is one of the commonest malignant diseases in the world. In this study the association of HBsAg and HCC, together with the role of other aetiological agents, is reviewed. Alfa-foeto-protein continues to be the best marker for early diagnosis of HCC. Surgical resection provides the only chance of cure, but the proportion of patients with resectable tumour is small. The hope for prevention of HCC lies in the use of a vaccine against hepatitis B virus.
S N
SN
Sinha
D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D003131:Combined Modality Therapy; D006509:Hepatitis B / Q000150:complications; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D011379:Prognosis; D000509:alpha-Fetoproteins / Q000032:analysis
D006514:Hepatitis B Surface Antigens; D000509:alpha-Fetoproteins